drugset / Trial / NCT07631091

Post-Operative Spinal Block Duration and Pain Relief After Hip Replacement Surgery: Comparing Single-Shot Spinal Ropivacaine and Bupivacaine

NCT07631091

Phase 4 Not yet recruiting 176 enrolled University of Turku Turku University Hospital · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to determine whether isobaric ropivacaine is more suitable than isobaric bupivacaine for spinal anesthesia in outpatient total hip arthroplasty (THA). The study will evaluate whether ropivacaine allows faster recovery of sensory and motor function while still providing adequate surgical anesthesia and postoperative pain control. Additional aims are to assess the effects of the anesthetic technique on same-day discharge rates, postoperative recovery, urinary retention, opioid consumption, and patient satisfaction after outpatient THA.

Timeline

Start
2026-06
Primary completion
2027-12
Completion
2028-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 11 mg Other
Comparator Ropivacaine Other / unclassified 15 mg Other

Indications